Heredia RD, Fernández CD, Rodríguez JA, Ballesteros HM

Idioma: Español
Referencias bibliográficas: 50
Paginas: 16-25
Archivo PDF: 53.28 Kb.

RESUMEN

En los últimos años, junto con los factores que podríamos llamar “clásicos” en el diagnóstico de la enfermedad renal (dígase anemia, hipertensión y diabetes), se considera que el estrés oxidativo sería otro factor a tener en cuenta en la patogénesis de la insuficiencia renal crónica progresiva. De hecho, el estrés oxidativo se ha señalado como un importante mediador patológico en muchas y muy diversas situaciones clínicas como la carcinogénesis, la arterioesclerosis, las enfermedades cardiovasculares y el envejecimiento. Esto parece ser debido a múltiples factores que incluyen un aumento de la producción de sustancias del metabolismo oxidativo y/o a una disminución de las defensas antioxidantes. Se realiza una revisión actualizada sobre el tema para evidenciar los cambios que puede provocar el estrés oxidativo en la insuficiencia renal asociada con la hipertensión, mostrando particularmente las serias alteraciones que provocan los radicales libres en la funcionalidad del riñón.

REFERENCIAS (EN ESTE ARTÍCULO)

1. González Rico M, Puchades MJ, García Ramón R, Saez G, Tormos MC, Miguel A. Effect of oxidative stress in patients with chronic renal failure. Nefrologia. 2006;26(2):218-25.

2. Yung LM, Leung FP, Yao X, Chen ZY, Huang Y. Reactive oxygen species in vascular wall. Cardiovasc Hematol Disord Drug Targets. 2006;6(1):1-19.

3. Hicks JJ, Torres-Ramos YD, Sierra-Vargas MP. Estrés oxidante, concepto y clasificación. Rev Endocrinol Nutr. 2006;14:223-6.

4. Valco M, Leibfritz D, Moncol J, Cronin MT, Mazur M, Telser J. Free radicals and antioxidants in normal physiological functions and human disease. Intern J Biochem Cell Biol. 2007;39:44-84.

5. Puchades Montesa MJ, González Rico MA, Solís Salguero MA, Torregrosa Maicas I, García IJ, Carrasco AM, et al. Estudio del estrés oxidativo en enfermedad renal avanzada. Nefrología. 2009;29(5):464-73.

6. Regano N, Iorio EL, Guglielmi A, Mazzuoli S, Francavilla A, Fregnan S, et al. The assessment of oxidative stress in clinical practice and its importance in nutrition. Nutr Ther Metabolism. 2008;26(4):149-62.

7. Schnwchenberg CHG. Oxigen radicals in cardiovascular-renal disease. Current Opinion Pharmacology. 2006;2:121-5.

8. Couchoud C, Moranne O, Frimat L, Labeeuw M, Allot V, Stengel B. Associations between comorbidities, treatment choice and outcome in the elderly with endstage renal disease. Nephrol Dial Transplant 2007;22:3246.

9. Ferretti G, Bacchetti T, Masciangelo S, Pallotta G. Lipid peroxidation in hemodialysis patients: effect of vitamin C supplementation. Clin Biochem. 2008;41:3816.

10. Karamouzis I, Sarafidis PA, Karamouzis M, Iliadis S, Haidich AB, Sioulis A, et al. Increase in oxidative stress but not in antioxidant capacity with advancing stages of chronic kidney disease. Am J Nephrol. 2008;28:397404.

11. Rysz J, Banach M, Stolarek RA, Pasnik J, Ciatkowska-Rysz A, Markuszewski L, et al. TNF-alfa priming effect on polymorphonuclear leukocytes reactive oxygen species generation and adhesion molecule expression in hemodialyzed patients. Arch Immunol Ther Exp. 2006;54:209-15.

12. Granqvist A, Nilsson UA, Ebefors K, Haraldsson B, Nyström J. Impaired glomerular and tubular antioxidative defense mechanisms in nephrotic syndrome. Am J Physiol Renal Physiol. 2010 Oct;299(4):F898-904.

13. Jurek A, Turyna B, Kubit P, Klein A. LDL susceptibility to oxidation and HDL antioxidant capacity in patients with renal failure. Clin Biochem. 2006;39:19-27.

14. Tian N, Moore RS, Braddy S, Rose RA, Gu JW, Hughson MD, et al. Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol. 2007 Dec;293(6):H3388-95.

15. Hirose M, Yasui T, Okada A, Hamamoto S, Shimizu H, Itoh Y, et al. Renal tubular epithelial cell injury and oxidative stress induce calcium oxalate crystal formation in mouse kidney. International Journal Of Urology: Official Journal Of The Japanese Urological Association. Int J Urol. 2010 Jan;17(1):83-92.

16. Valko M, Morris H, Cronin M. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161-208.

17. Izzet T, Osman K, Ethem U, Nihat Y, Ramazan K, Mustafa D, et al. Oxidative stress in portal hypertension-induced rats with particular emphasis on nitric oxide and trace metals. World J Gastroenterol. 2005;21(11):3570-3.24.25.26.

18. Myhal' LIa, Korol' LV, Dudar IO, Zheltovs'ka NI, Kindi- TV. Activity of tubular enzymes and lipoperoxidation processes in patients with progressive diabethic nephropathy. Lik Sprava. 2006;(1-2):18-22.

19. Cottone S, Mule G, Lorito MC. Oxidant stress inversely relates to renal function in hypertension [abstract]. J Hypertens. 2007;25(suppl 2):S64.

20. Tziomalos K, Athyros VG, Karagiannis A, Mikhailidis DP. Endothelial function arterial stiffness and lipid lowering drugs. Expert Opin Ther Targets. 2007;11:1143 -60.

21. Patterson ME, Mouton CR, Mullins JJ, Mitchell KD. Interactive effects of superoxide anion and nitric oxide on blood pressure and renal hemodynamics in transgenic rats with inducible malignant hypertension. Am J Physiol Renal Physiol. 2005;289:F754F759.

22. Chen MF, Chang CL, Liou SY. Increase in resting levels of superoxide anion in the whole blood of uremic patients on chronic hemodialysis. Blood Purif. 2007;16:290-300.

23. Peixoto EB, Pessoa BS, Biswas SK, Lopes de Faria JB. Antioxidant SOD mimetic prevents NADPH oxidase-induced oxidative stress and renal damage in the early stage of experimental diabetes and hypertension. Am J Nephrol. 2009;29(4):309-18.

24. Sachse A, Wolf G. Angiotensin II induced reactive oxygen species and the kidney. J Am Soc Nephrol. 2007;18:2439-46.

25. Castilla P, Dávalos A, Teruel JL, Cerrato F, Fernández-Lucas M, Merino JL, et al. Comparative effects of dietary supplementation with red grape juice and vitamin E on production of superoxide by circulating neutrophil NADPH oxidase in hemodialysis patients. Am J Clin Nutr. 2008;87:1053106.

26. Dikalov S. Interactions of peroxynitrite with uric acid in the presence of ascorbate and thiols: Implications for uncoupling endothelial nitric oxide synthase. Biochem Pharmacol. 2005;70:34354.

27. Feletou M, Vanhoutte PM. Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture). Am J Physiol Heart Circ Physiol. 2006;291(3):985-1002.

28. Schleicher E, Friess U. Oxidative stress, AGE, and atherosclerosis. Kidney Int. 2007;72:S17-S26.

29. Farbom P, Wahlstrand B, Almgren P, Skrtic S, Lanke J, Weiss L, et al. Interaction between renal function and microalbuminuria for cardiovascular risk in hypertension: the Nordic diltiazem study. Hypertension. 2008;52:11522.

30. Morena M, Delosc S, Dupuy AM, Canaud B, Cristol JP. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int. 2005;9:37-46.

31. Zoccali C. Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective. Kidney Intern. 2006;70:2633.

32. Mc Intyre M, Borh DF, Dominianak AF. Endothelial function in hypertension. The role of superoxide anion. Hypertension. 2006;34:539-45.

33. Rodríguez-Iturbe B, Zhan CD, Quiroz Y, Sindhu RK, Nosratola D. Vaziri. Antioxidant- rich diet relieves hypertension and reduces renal inmune infiltration in spontaneously hypertensive rats. Hypertension. 2003;41:341-6.

34. Rajasekaran NS, Sathyanarayanan S, Devaraj NS, Devaraj H. Chronic depletion of glutathione (GSH) and minimal modification of LDL in vivo: its prevention by glutathione mono ester (GME) therapy. Biochim Biophys Acta. 2005;1741:10312.

35. Merino A, Nogueras S, Buendía P, Ojeda R, Carracedo J, Ramirez-Chamond R, et al. Microinflammation and endothelial damage in hemodialysis. Contrib Nephrol. 2008;161:83-88.

36. Dirican M, Sarandöl E, Serdar Z, Ocak N, Dilek K. Oxidative status and prevalent cardiovascular disease in patients with chronic renal failure trated by hemodialysis. Clin Nephrol. 2007;68:144-50.

37. Dean PJ. Redefining oxidative stress. Antioxidants & Redox Signaling. 2006;8(9):1865-79.

38. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of oxidative damage in human desease. Clin Chem. 2006;52:601-23.

39. De Vecchi AF, Bamonti F, Novembrino C, et al. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients. Nephrol Dial Transplant. 2009;24(8):2524-29.

40. Moradi H, Pahl MV, Elahimer R, Vaziri ND. Impaired antioxidant activity of high density lipoprotein in chronic kidney disease. Transpl Res. 2009;153(2):77-85.

41. Russo C, Olivieri O, Girelli D, Faccini G, Zenari Ml, Lombardi S. Antioxidant status and lipid peroxidation in patiens with hypertension. J Hypertens. 1998;16(9):1267-71.

42. Ward NC, Hodgson JM, Puddey IB, Mori TA, Beilin LJ, Croft KD. Oxidative stress in human hypertension: association with antihypertensive treatment, gender nutrition, and lifestyle. Free Radic Biol Med. 2004;36:226-32.

43. Sontia B, Touyz R. Role of magnesium in hypertension. Arch Biochem Bioph. 2007;458(1):33-9.

44. Chakraborty I, Kunti S, Bandyopadhyay M, Dasgupta A. Evaluation of serum zinc level and plasma SOD activity in senile cataract patients under oxidative stress. Indian J Clin Biochem. 2007;22(2):109-13.

45. Morena M, Jaussent I, Chalabi L, Bargnoux AS, Dupuy AM, Badiou S, et al. Biocompatibility of heparin-grafted hemodialysis membranes: impact on monocyte chemoattractant protein-1 circulating level and oxidative status. Hemodialysis International. International Symposium on Home Hemodialysis. Hemodial Int. 2010 Oct;14(4):403-10.

46. Takouli L, Hadjiyannakos D, Metaxaki P, Sideris V, Filiopoulos V, Anogiati A, et al. Vitamin E-coated cellulose acetate dialysis membrane: long-term effect on inflammation and oxidative stress. Ren Fail. 2010 Jan;32(3):287-93.

47. Himmelfarb J. Uremic toxicity, oxidative stress, and hemodialysis as renal replacement therapy. Semin Dial 2009 Nov-Dec;22(6):636-43.

48. Ming-Sheng Z, Hernández Schuman I, Jaimes EA, Raij L. Renoprotection by statins is linked to a decrease in renal oxidative stress, TGFb and fibronectin with concomitant increase in nitric oxide bioavailability. Am J Physiol Renal Physiol. 2008;295:F53F59.

49. Cottone S, Nardi E, Mule G, Vadala A, Lorito MC, Riccobene R, et al. Association between biomarkers of inflammation and left ventricular hypertrophy in moderate chronic kidney disease. Clin Nephrol. 2007;67:209-16.

50. Cottone S, Mulè G, Guarneri M, Palermo A, Lorito MC, Riccobene R, et al. Endothelin-1 and F2 isoprostane relate to and predict renal dysfunction in hypertensive patients. Nephrol Dial Trasplant. 2009;24:497- 503.